Pharmacological management of neuropathic pain following spinal cord injury
- PMID: 18484790
- DOI: 10.2165/00023210-200822060-00002
Pharmacological management of neuropathic pain following spinal cord injury
Abstract
Spinal cord injury (SCI) has a number of severe and disabling consequences, including chronic pain, and around 40% of patients develop persistent neuropathic pain. Pain following SCI has a detrimental impact on the patient's quality of life and is a major specific healthcare problem in its own right. Thus far, there is no cure for the pain and oral pharmaceutical intervention is often inadequate, commonly resulting in a reduction of only 20-30% in pain intensity. Neuropathic pain sensations are characterized by spontaneous persistent pain and a range of abnormally evoked responses, e.g. allodynia (pain evoked by normally non-noxious stimuli) and hyperalgesia (an increased response to noxious stimuli). Neuropathic pain following SCI may be present at or below the level of injury. Oral pharmacological agents used in the treatment of neuropathic pain act either by depressing neuronal activity, by blocking sodium channels or inhibiting calcium channels, by increasing inhibition via GABA agonists, by serotonergic and noradrenergic reuptake inhibition, or by decreasing activation via glutamate receptor inhibition, especially by blocking the NMDA receptor. At present, only ten randomized, double-blind, controlled trials have been performed on oral drug treatment of pain after SCI, the results of most of which were negative. The studies included antidepressants (amitriptyline and trazodone), antiepileptics (gabapentin, pregabalin, lamotrigine and valproate) and mexiletine. Gabapentin, pregabalin and amitriptyline showed a significant reduction in neuropathic pain following SCI. Cannabinoids have been found to relieve other types of central pain, and serotonin noradrenaline reuptake inhibitors as well as opioids relieve peripheral neuropathic pain and may be used to treat patients with SCI pain.
Similar articles
-
Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).Ann Phys Rehabil Med. 2009 Mar;52(2):124-41. doi: 10.1016/j.rehab.2008.12.011. Epub 2009 Feb 21. Ann Phys Rehabil Med. 2009. PMID: 19909703
-
Inhibition of T-Type Calcium Channels With TTA-P2 Reduces Chronic Neuropathic Pain Following Spinal Cord Injury in Rats.J Pain. 2023 Sep;24(9):1681-1695. doi: 10.1016/j.jpain.2023.05.002. Epub 2023 May 9. J Pain. 2023. PMID: 37169156
-
Above-level mechanical hyperalgesia in rats develops after incomplete spinal cord injury but not after cord transection, and is reversed by amitriptyline, morphine and gabapentin.Pain. 2010 Oct;151(1):184-193. doi: 10.1016/j.pain.2010.07.007. Epub 2010 Aug 1. Pain. 2010. PMID: 20675054
-
Administration of ONO-2506 suppresses neuropathic pain after spinal cord injury by inhibition of astrocytic activation.Spine J. 2019 Aug;19(8):1434-1442. doi: 10.1016/j.spinee.2019.04.006. Epub 2019 Apr 8. Spine J. 2019. PMID: 30974239
-
Spinal cord injury pain: mechanisms and management.Curr Pain Headache Rep. 2012 Jun;16(3):207-16. doi: 10.1007/s11916-012-0259-x. Curr Pain Headache Rep. 2012. PMID: 22392531 Review.
Cited by
-
Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury.J Pain Res. 2013 Jul 11;6:539-47. doi: 10.2147/JPR.S45966. Print 2013. J Pain Res. 2013. PMID: 23874121 Free PMC article.
-
Motor cortex stimulation suppresses cortical responses to noxious hindpaw stimulation after spinal cord lesion in rats.Brain Stimul. 2014 Mar-Apr;7(2):182-9. doi: 10.1016/j.brs.2013.12.013. Epub 2013 Dec 27. Brain Stimul. 2014. PMID: 24468093 Free PMC article.
-
Co-administration of human adipose-derived stem cells and low-level laser to alleviate neuropathic pain after experimental spinal cord injury.Stem Cell Res Ther. 2019 Jun 24;10(1):183. doi: 10.1186/s13287-019-1269-y. Stem Cell Res Ther. 2019. PMID: 31234929 Free PMC article.
-
Pilot study of feasibility and effect of anodal transcutaneous spinal direct current stimulation on chronic neuropathic pain after spinal cord injury.Spinal Cord. 2019 Jun;57(6):461-470. doi: 10.1038/s41393-019-0244-x. Epub 2019 Jan 30. Spinal Cord. 2019. PMID: 30700853
-
Pain After Spinal Cord Injury Is Associated With Abnormal Presynaptic Inhibition in the Posterior Nucleus of the Thalamus.J Pain. 2018 Jul;19(7):727.e1-727.e15. doi: 10.1016/j.jpain.2018.02.002. Epub 2018 Mar 2. J Pain. 2018. PMID: 29481977 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical